Nuvalent (NUVL) Cash from Financing Activities (2020 - 2026)

Nuvalent (NUVL) posted Cash from Financing Activities of $9.8 million for Q1 2026, down 98.04% on a QoQ basis from $500.3 million in Q4 2025, and up 115.5% year-over-year from $4.5 million in Q1 2025.

Nuvalent (NUVL) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Nuvalent's Cash from Financing Activities history runs 7 years deep, the most recent figure standing at $9.8 million for Q1 2026.

  • Quarterly Cash from Financing Activities rose 115.5% year-over-year to $9.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $520.6 million (down 8.26% YoY) and the FY2025 annual result came in at $515.3 million, down 9.41% from the prior year.
  • Cash from Financing Activities was $9.8 million for Q1 2026 at Nuvalent, down from $500.3 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $550.3 million in Q3 2024 and bottomed at -$768000.0 in Q1 2022.
  • A 5-year average of $98.8 million and a median of $4.8 million in 2025 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2022 — Cash from Financing Activities plunged 107.68% — and 2024, when it jumped 35311.76%.
  • Nuvalent's Cash from Financing Activities stood at $248.7 million in 2022, then soared by 34.08% to $333.4 million in 2023, then slumped by 97.45% to $8.5 million in 2024, then jumped by 5791.0% to $500.3 million in 2025, then tumbled by 98.04% to $9.8 million in 2026.
  • Business Quant data shows NUVL's Cash from Financing Activities at $9.8 million in Q1 2026, $500.3 million in Q4 2025, and $4.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 30.14 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 68.63 Mn
4 NuCana 279.75 Bn 279.75 Bn - 9,311.16
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 238.74 Mn
10 Nuvalent 9.75 Bn 9.75 Bn - 9.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 9.80 Mn
Mar 31, 2026 9.80 Mn
Dec 31, 2025 500.26 Mn
Dec 31, 2025 500.26 Mn
Sep 30, 2025 4.77 Mn
Sep 30, 2025 4.77 Mn
Jun 30, 2025 5.76 Mn
Jun 30, 2025 5.76 Mn
Mar 31, 2025 4.55 Mn
Mar 31, 2025 4.55 Mn
Dec 31, 2024 8.49 Mn
Dec 31, 2024 8.49 Mn
Sep 30, 2024 550.27 Mn
Sep 30, 2024 550.27 Mn
Jun 30, 2024 4.14 Mn
Jun 30, 2024 4.14 Mn
Mar 31, 2024 5.99 Mn
Mar 31, 2024 5.99 Mn
Dec 31, 2023 333.42 Mn
Dec 31, 2023 333.42 Mn